Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb 15;19(4):2185.
doi: 10.3390/ijerph19042185.

The Quality and Reliability of Information in the Summaries of Product Characteristics

Affiliations
Review

The Quality and Reliability of Information in the Summaries of Product Characteristics

Ewelina Drelich et al. Int J Environ Res Public Health. .

Abstract

The Summary of Product Characteristics (SmPC) is an obligatory document concerning a medicine required (among other things) for the authorization of a medicinal product. The purpose of the SmPC is to provide product information to healthcare professionals. A necessary condition for this is to ensure that the SmPC is clear and precise. However, neither European nor national legislation obliges marketing authorization holders to review the SmPC in terms of its readability and understandability prior to the registration of a medicine. To date, research on SmPCs has focused on accuracy and completeness; however, the literature lacks information on the extent to which SmPCs meet the needs of healthcare professionals concerning the readability of the information they contain. The main objective of this article is to point out the lack of precision in the legal provisions for the preparation of SmPCs concerning the comprehensibility of the provisions. The article points to the lack of testing of the SmPC in terms of accessibility and transparency for healthcare professionals, highlighting that the document does not meet the needs of healthcare professionals in providing adequate information about medicines. It shows that the current rules and guidelines for the preparation of the registration dossier for a medicinal product are not entirely precise and contain numerous shortcomings.

Keywords: SmPC; medication handling; medicinal product; patient safety.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. European Commission EudraLex—Volume 2—Pharmaceutical Legislation on Notice to Applicants and Regulatory Guidelines for Medicinal Products for Human Use. 2019. [(accessed on 22 March 2021)]. Available online: http://ec.europa.eu/health/documents/eudralex/vol.
    1. European Commission DIRECTIVE 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community Code Relating to Medicinal Products for Human Use. 2001. [(accessed on 22 March 2021)]. Available online: http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=CONSLEG:2001L0083:2....
    1. European Commission A Guideline on Summary of Product Characteristics (SmPC) 2009. [(accessed on 21 March 2021)]. Available online: http://ec.europa.eu/health/files/eudralex/vol-2/c/smpc_guideline_rev2_en...
    1. Hallerste A., Fürst W., Mezzasalma R. Physicians prefer greater detail in the biosimilar label (SmPC)—Results of a survey across seven European countries. Regul. Toxicol. Pharmacol. 2016;77:275–281. doi: 10.1016/j.yrtph.2016.03.021. - DOI - PubMed
    1. Mathioudakis A., Rousalova I., Gagnat A.A., Saad N., Hardavella G. How to keep good clinical records. Breathe. 2016;12:369–373. doi: 10.1183/20734735.018016. - DOI - PMC - PubMed

LinkOut - more resources